ICPT liver drug, Ocaliva, was already approved for fast-track approval 6 weeks ago. What do you think the chances are for FDA to approve fast-track approval and then deny approval subsequenty? Kinda doesn't make sense even with the current mental midgets on the FDA panel. So the smart money has already priced that in, hence the lack of trading excitement. The real question is if Ocaliva can be approved for NASH. A decision which will probably not be made until 2018. So everyone stay calm and stop overanalyzing every tick.
It does - dozens of drugs in clinical stages. Good article posted today by Motley Fool. Read it.
XON is so much more than Zika. Unfortunately CNBC keeps pumping the Zika angle. With a little DD one can see the huge potential of XON and it's synthetic bio products. Zika is only about 0.1% of the story here. Let's all get over it.
This company is still way overvalued. Talk to me about investing in it when it starts to show a profit. No such thing even in sight.
Talk about beating a dead horse! I mean even Andrew Left is saying VRX is a good long here.
XON is so much more than Zica. Just read about the Company and it's prospects. With the world population exploding synthetic bio is gonna be the biggest thing. All big pharmas are eventually gonna fall over themselves trying to scoop this up.
He said a few months ago VRX should go down to $50 as fair valuation. Today he says it will never go up to $50. Who knows? Certainly he was right to short VRX at $120. But he has been beating up on MNK with no luck. Reminds me of Ackman and HLF!
I'm sure I read somewhere to make real money you gotta buy when everyone is selling. Well, everyone is selling this one.
Four words for the Board to dramatically increase value for the shareholders: Spin Out Real Estate
Airlines are getting into retail business. Retail in today's sentiment is same as DEATH.
The fact that one fund owns 53% of outstanding shares makes this so much more of a juicy target for short manipulation - there is just so much less liquidity. Spotlight did their targeting homework. Now we need SEC to do theirs.
You probably will post that Price Waterhouse is owned by XON and the whole set up is a massive fraud, right? LOL
And if no accounting malpractice, then we'll jump back to $40+ in days. Place your bets.